The global pharmaceutical stability and storage services market size is estimated at USD 3.38 billion in 2024, grew to USD 3.56 billion in 2025 and is predicted to surpass around USD 5.88 billion by 2034, expanding at a CAGR of 5.69% between 2024 and 2034. The North America xxx market size accounted for USD 1.83 billion in 2024 and is anticipated to grow at a fastest CAGR of 5.83% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Stability and Storage Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Stability and Storage Services Market, by Services, 2024-2034
8.1.1 Stability
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Storage
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cold
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Non-cold
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Pharmaceutical Stability and Storage Services Market, by Molecule, 2024-2034
9.1.1. Small Molecule
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Large Molecule
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Pharmaceutical Stability and Storage Services Market, by Mode, 2024-2034
10.1.1. In-house
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Outsourcing
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Services (2021-2034)
11.1.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.1.3. Market Revenue and Forecast, by Mode (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Mode (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Services (2021-2034)
11.2.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.2.3. Market Revenue and Forecast, by Mode (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Mode (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Services (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Mode (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Services (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Mode (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Services (2021-2034)
11.3.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.3.3. Market Revenue and Forecast, by Mode (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Mode (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Services (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Mode (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Services (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Mode (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Mode (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Services (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Mode (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Services (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Mode (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.5.3. Market Revenue and Forecast, by Mode (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Services (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Mode (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Services (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Molecule (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Mode (2021-2034)
12.1. Catalent, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Charles River Laboratories International, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Almac Group
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Eurofins Scientific
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Lucideon Limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Intertek Group Plc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Alcami Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Element Materials Technology
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Q1 Scientific
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BioLife Solutions
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample